S
XBI icon

SignatureFD’s State Street SPDR S&P Biotech ETF XBI Stock Holding History

SignatureFD’s Portfolio XBI Stock Details XBI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$132K Buy
1,033
+8
+0.8% +$999 ﹤0.01% 1221
2025
Q4 		$125K Sell
1,025
-660
-39% -$75.7K ﹤0.01% 1208
2025
Q3 		$169K Hold
1,685
– – ﹤0.01% 1033
2025
Q2 		$140K Sell
1,685
-100
-6% -$7.98K ﹤0.01% 1075
2025
Q1 		$145K Sell
1,785
-549
-24% -$49.1K ﹤0.01% 1033
2024
Q4 		$210K Buy
2,334
+598
+34% +$57.9K ﹤0.01% 855
2024
Q3 		$171K Buy
1,736
+12
+0.7% +$1.18K ﹤0.01% 949
2024
Q2 		$160K Buy
1,724
+1
+0.1% +$90 ﹤0.01% 922
2024
Q1 		$164K Hold
1,723
– – ﹤0.01% 924
2023
Q4 		$154K Sell
1,723
-425
-20% -$31.6K ﹤0.01% 909
2023
Q3 		$157K Buy
2,148
+1,024
+91% +$81.8K ﹤0.01% 834
2023
Q2 		$93.5K Buy
1,124
+4
+0.4% +$335 ﹤0.01% 1095
2023
Q1 		$85.4K Hold
1,120
– – ﹤0.01% 1123
2022
Q4 		$93K Hold
1,120
– – ﹤0.01% 1044
2022
Q3 		$89K Buy
1,120
+20
+2% +$1.69K ﹤0.01% 1017
2022
Q2 		$82K Buy
1,100
+941
+592% +$70.6K ﹤0.01% 1070
2022
Q1 		$14K Sell
159
-154
-49% -$14.2K ﹤0.01% 2021
2021
Q4 		$35K Hold
313
– – ﹤0.01% 1516
2021
Q3 		$39K Sell
313
-2
-0.6% -$258 ﹤0.01% 1446
2021
Q2 		$43K Buy
315
+215
+215% +$28.3K ﹤0.01% 1352
2021
Q1 		$14K Hold
100
– – ﹤0.01% 1722
2020
Q4 		$14K Buy
+100
New +$12.8K ﹤0.01% 1587

Other funds holding XBI

BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

SignatureFD's XBI Position: Q1 2026 in Review

SignatureFD increased its State Street SPDR S&P Biotech ETF (XBI) stake by 0.78% in Q1 2026, buying an estimated $999 and bringing the position to 1,033 shares worth $132K. The position accounts for ﹤0.01% of the portfolio, ranked #1221.

SignatureFD first reported a position in XBI in Q4 2020 and has held it in 22 quarters since. The position peaked at $210K in Q4 2024. 813 funds tracked by Wall St. Rank hold XBI as of Q1 2026.

  • SignatureFD held 1,033 shares of State Street SPDR S&P Biotech ETF worth $132K as of Q1 2026.
  • SignatureFD bought 8 State Street SPDR S&P Biotech ETF shares in Q1 2026, an estimated $999.
  • State Street SPDR S&P Biotech ETF made up ﹤0.01% of SignatureFD's portfolio in Q1 2026, its #1221 holding.
  • SignatureFD first reported a position in State Street SPDR S&P Biotech ETF in Q4 2020 and has held it in 22 quarters since.
  • SignatureFD's State Street SPDR S&P Biotech ETF position peaked at $210K in Q4 2024.
  • 813 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q1 2026.

Based on SignatureFD's 13F filing for Q1 2026, filed 7 Apr 2026.